Thomas Collins, MD
Transplant Surgery · Denver, CONPI 1194750083
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,414 of the $1,970 with a category attached, or 71.8%. 25 manufacturers reported payments, led by Intuitive Surgical at 26.6% of the total. That places this record below the midpoint for transplant surgery clinicians in CO, where the typical reported total is $3,794.
Across 32 payments — averaging $61.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$523
- Medtronic$159
- Werfen USA LLC$148
- Intercept Pharmaceuticals, Inc.$141
- Boston Scientific$128
- Dova Pharmaceuticals$125
- plus $746 from 19 others
What the payments were for
- Travel & lodging$52327%
- Food & beverage$1,41472%
- Education$332%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 2 | $523 |
| Medtronic | 2 | $159 |
| Werfen USA LLC | 1 | $148 |
| Intercept Pharmaceuticals, Inc. | 2 | $141 |
| Boston Scientific | 1 | $128 |
| Dova Pharmaceuticals | 1 | $125 |
| Bayer | 1 | $125 |
| Gilead | 1 | $105 |
| Madrigal Pharmaceuticals | 2 | $64 |
| Astellas Pharma US Inc | 3 | $56 |
| KCI USA, Inc. | 2 | $53 |
| Integra Lifesciences Corporation | 1 | $34 |
| Veloxis Pharmaceuticals, Inc. | 1 | $32 |
| Octapharma USA, Inc. | 1 | $31 |
| Healthmyne, Inc. | 1 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $28 |
| Ipsen Biopharmaceuticals, Inc | 1 | $27 |
| Innovation Technologies Inc | 1 | $26 |
| Merck | 1 | $24 |
| Shionogi Inc | 1 | $20 |
| Biocompatibles, Inc. | 1 | $19 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
| Novartis | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$504
- ROTEM$148
- TheraSphere Y90 Glass Microspheres 10 GBq$128
- Signia$127
- OCALIVA$125
- DOPTELET$125
- Stivarga$125
- Epclusa$105
How this compares
$1,970 in reported general payments places this provider in the 40th percentile of 22 transplant surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant surgery in Denver
- Alexander WisemanDenver$177K
- Thomas HeffronDenver$18K
- Giuseppe D'amicoDenver$12K
- Daniel KuehlerDenver$7K
- Oya AndacogluDenver$4K
- James LimDenver$877
- Massimo AsolatiDenver$743
- Thomas PshakAurora$33K
- Peter KennealeyAurora$31K
- Hunter MooreAurora$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.